Atlas Trials

A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

Clinical trial NCT03792152 · UNKNOWN

Trial details

NCT number
NCT03792152
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Atrial FibrillationLeft Atrial Appendage ThrombosisRivaroxaban
Start date
2019-06-01
Primary completion
2022-01-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.